Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Trulieve Cannabis Corp. TCNNF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
49/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$47.21
+629.4%

Trulieve Cannabis Corp. (TCNNF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $6.47. It has a SharesGrow Score of 49/100, indicating a mixed investment profile with 2 out of 7 criteria passed.

Analyst consensus target is TCNNF = $47 (+629.4% upside).

Financials: revenue is $1.2B, -0.9%/yr average growth. Net income is $118M (loss), growing at -20.9%/yr. Net profit margin is -9.9% (negative). Gross margin is 50.2% (-4.8 pp trend).

Balance sheet: total debt is $670M against $1.2B equity (Debt-to-Equity (D/E) ratio 0.58, moderate). Current ratio is 4.43 (strong liquidity). Debt-to-assets is 24.4%. Total assets: $2.7B.

Analyst outlook: 9 / 9 analysts rate TCNNF as buy (100%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 15/100 (Fail), Past 0/100 (Fail), Health 50/100 (Partial), Moat 65/100 (Partial), Future 100/100 (Pass), Income 10/100 (Fail).

$47.21
▲ 629.45% Upside
Average Price Target
Based on 9 Wall Street analysts offering 12-month price targets for Trulieve Cannabis Corp., the average price target is $47.21, with a high forecast of $65.00, and a low forecast of $18.00.
Highest Price Target
$65.00
Average Price Target
$47.21
Lowest Price Target
$18.00

TCNNF SharesGrow Score Overview

57/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 100/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 65/100
Gross margin is + market cap
FUTURE 100/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — TCNNF

✓
VALUE Pass
100/100
TCNNF trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $47, implying +626.2% from the current price $6. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
✗
GROWTH Fail
15/100
TCNNF: -0.9%/yr revenue is, -20.9%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
50/100
Balance sheet TCNNF: Debt-to-Equity (D/E) ratio 0.58 (moderate), Current ratio is 4.43 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
65/100
TCNNF: Gross margin is 50.2% (-4.8 pp trend), $1B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 65/100. ≥ 70 = Pass.
View details →
✓
FUTURE Pass
100/100
Analyst outlook: 9 / 9 analysts rate TCNNF as buy (100%). Analyst consensus target is $47 (+626.2% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
TCNNF: Net profit margin is -9.9%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range3.02-11.83
Volume34.88K
Avg Volume (30D)219.97K
Market Cap$1.25B
Beta (1Y)1.58
Share Statistics
EPS (TTM)-0.62
Shares Outstanding$191.32M
IPO Date2018-09-27
Employees6,000
CEOKimberly Rivers
Financial Highlights & Ratios
Revenue (TTM)$1.2B
Gross Profit$603.92M
EBITDA$334.08M
Net Income$-118.42M
Operating Income$161.57M
Total Cash$255.07M
Total Debt$670.28M
Net Debt$415.21M
Total Assets$2.75B
Price / Earnings (P/E)-10.4
Price / Sales (P/S)1.04
Analyst Forecast
1Y Price Target$52.92
Target High$65.00
Target Low$18.00
Upside+717.6%
Rating ConsensusBuy
Analysts Covering9
Buy 100% Hold 0% Sell 0%
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINCA89788C1041

Price Chart

Track all markets on TradingView
TCNNF
Trulieve Cannabis Corp. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
3.02 52WK RANGE 11.83

People Also View

CURLF
CURLF
Curaleaf Holdings, Inc.
$2.40
+0.04%
 GTBIF
GTBIF
Green Thumb Industries Inc.
$6.76
+0.30%
 CRLBF
CRLBF
Cresco Labs Inc.
$0.92
+0.48%
 PLNHF
PLNHF
Planet 13 Holdings Inc.
$0.91
+2.13%
 GRWG
GRWG
GrowGeneration Corp.
$1.08
+2.86%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message